93 related articles for article (PubMed ID: 18922695)
1. Lower recurrence risk through mammographic screening reduces breast cancer treatment costs.
Kauhava L; Immonen-Räihä P; Parvinen I; Holli K; Pylkkänen L; Kaljonen A; Helenius H; Kronqvist P; Klemi PJ
Breast; 2008 Dec; 17(6):550-4. PubMed ID: 18922695
[TBL] [Abstract][Full Text] [Related]
2. Mammographic screening reduces risk of breast carcinoma recurrence.
Immonen-Räihä P; Kauhava L; Parvinen I; Holli K; Kronqvist P; Pylkkänen L; Helenius H; Kaljonen A; Räsänen O; Klemi PJ
Cancer; 2005 Feb; 103(3):474-82. PubMed ID: 15611974
[TBL] [Abstract][Full Text] [Related]
3. Recurrent cancer after breast-conserving surgery with radiation therapy for ductal carcinoma in situ: mammographic features, method of detection, and stage of recurrence.
Pinsky RW; Rebner M; Pierce LJ; Ben-David MA; Vicini F; Hunt KA; Helvie MA
AJR Am J Roentgenol; 2007 Jul; 189(1):140-4. PubMed ID: 17579163
[TBL] [Abstract][Full Text] [Related]
4. Mammographic appearance of recurrent breast cancer after breast conservation therapy.
Weinstein SP; Orel SG; Pinnamaneni N; Tchou J; Czerniecki B; Boraas M; Rosato E; Solin LJ
Acad Radiol; 2008 Feb; 15(2):240-4. PubMed ID: 18206623
[TBL] [Abstract][Full Text] [Related]
5. [Cost-benefit analysis of a mammography screening program extended to all the national territory].
Vanara F; Zappa M; Rosselli del Turco M; Segnan N; Paci E; Ponti A
Epidemiol Prev; 1997; 21(2):118-28. PubMed ID: 9378179
[TBL] [Abstract][Full Text] [Related]
6. High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer.
Park CC; Rembert J; Chew K; Moore D; Kerlikowske K
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):75-9. PubMed ID: 18692323
[TBL] [Abstract][Full Text] [Related]
7. A patient-level calibration framework for evaluating surveillance strategies: a case study of mammographic follow-up after early breast cancer.
Bessen T; Karnon J
Value Health; 2014 Sep; 17(6):669-78. PubMed ID: 25236990
[TBL] [Abstract][Full Text] [Related]
8. Cost of breast cancer treatment. A 4-year longitudinal study.
Legorreta AP; Brooks RJ; Leibowitz AN; Solin LJ
Arch Intern Med; 1996 Oct; 156(19):2197-201. PubMed ID: 8885818
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer screening by mammography in women aged under 50 years in Japan.
Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
[TBL] [Abstract][Full Text] [Related]
10. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
[TBL] [Abstract][Full Text] [Related]
11. Costs and mortality of recurrent versus de novo hormone receptor-positive/HER2(-) metastatic breast cancer.
Engel-Nitz NM; Hao Y; Becker LK; Gerdes R
J Comp Eff Res; 2015 Aug; 4(4):303-14. PubMed ID: 26274792
[TBL] [Abstract][Full Text] [Related]
12. Lower costs of hospital treatment of breast cancer through a population-based mammography screening programme.
Kauhava L; Immonen-Räihä P; Parvinen I; Helenius H; Kaljonen A; Räsänen O; Pylkkänen L; Klemi PJ
Eur J Public Health; 2004 Jun; 14(2):128-33. PubMed ID: 15230496
[TBL] [Abstract][Full Text] [Related]
13. Population-based mammography screening results in substantial savings in treatment costs for fatal breast cancer.
Kauhava L; Immonen-Räihä P; Parvinen I; Holli K; Kronqvist P; Pylkkänen L; Helenius H; Kaljonen A; Räsänen O; Klemi PJ
Breast Cancer Res Treat; 2006 Jul; 98(2):143-50. PubMed ID: 16538536
[TBL] [Abstract][Full Text] [Related]
14. Mammographic detection of recurrent cancer in the irradiated breast.
Stomper PC; Recht A; Berenberg AL; Jochelson MS; Harris JR
AJR Am J Roentgenol; 1987 Jan; 148(1):39-43. PubMed ID: 3491522
[TBL] [Abstract][Full Text] [Related]
15. Mammographic findings in breast cancer patients, who were treated with breast conserving therapy.
Tangkaratt S
J Med Assoc Thai; 2004 Dec; 87(12):1439-43. PubMed ID: 15822537
[TBL] [Abstract][Full Text] [Related]
16. Detecting nonpalpable recurrent breast cancer: the role of routine mammographic screening of transverse rectus abdominis myocutaneous flap reconstructions.
Lee JM; Georgian-Smith D; Gazelle GS; Halpern EF; Rafferty EA; Moore RH; Yeh ED; D'Alessandro HA; Hitt RA; Kopans DB
Radiology; 2008 Aug; 248(2):398-405. PubMed ID: 18539887
[TBL] [Abstract][Full Text] [Related]
17. Mammography in symptomatic and asymptomatic patients.
Stomper PC; Gelman RS
Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
[TBL] [Abstract][Full Text] [Related]
18. [Mammography and sonography in the diagnosis of recurrence after breast-preserving therapy of breast carcinoma].
Buchberger W; Hamberger L; Schön G; Steixner G; Fritsch E
Rofo; 1991 Jun; 154(6):650-6. PubMed ID: 1648770
[TBL] [Abstract][Full Text] [Related]
19. Mammographic appearance of recurrent breast carcinoma in six patients with TRAM flap breast reconstructions.
Helvie MA; Wilson TE; Roubidoux MA; Wilkins EG; Chang AE
Radiology; 1998 Dec; 209(3):711-5. PubMed ID: 9844663
[TBL] [Abstract][Full Text] [Related]
20. Effect of screening mammography on the surgery of breast cancer in Finland: a population-based analysis during the years 1985-2004.
Paajanen H; Kyhälä L; Varjo R; Rantala S
Am Surg; 2006 Feb; 72(2):167-71. PubMed ID: 16536250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
